Visceral Leishmaniasis: Successful Vaccine Trial In Dogs
Visceral leishmaniasis, which is the most severe form of that group of diseases, affects 500 000 people in the world each year. It is caused by a protozoan, Leishmania infantum, transmitted by sand fly bites. There is no vaccine for this disease, which can rapidly lead to death if no treatment is given. In the most heavily affected areas, the dog population is hit heavily by infection. It acts as...Potential vaccine developed for deadly leishmaniasis disease
Development of a fundamentally new "candidate," or potential, vaccine for visceral leishmaniasis, a parasitic disease that kills about 60,000 people annually, is reported in the current issue of . Spread by the bite of infected female sand flies, visceral leishmaniasis infects about 500,000 people annually, with the majority of cases occurring in India, Bangladesh, Ne...Effective Vaccine for Leishmaniasis in the Pipeline
Leishmaniasis is a parasitic disease that kills about 60,000 people annually. It spreads by the bite of infected female sand flies. // Visceral leishmaniasis infects about 500,000 people annually mainly in India, Bangladesh, Nepal, Sudan and Brazil. The most common drugs to treat leishmaniasis have serious side effects and are expensive. Symptoms of visceral leishmaniasis include fever, w...Researchers Hopeful About Vaccine For Leishmaniasis
Leishmaniasis or black fever as it is commonly called, is a tropical disease that kills nearly about 60, 000 people, every year//. We might soon be able to put an end to this deadly killer, say Swiss researchers who claim to have produced a vaccine that would protect humans and animals. The disease is most commonly seen in Bangladesh, Sudan, India, Nepal, and Brazil. The spleen is th...IDRI and Chembio to Develop Tests for Leishmaniasis and Leprosy
The Seattle-based Infectious Disease Research Institute (IDRI) and Chembio Diagnostics, Inc. (OTC Bulletin Board: CEMI) have entered into two research and development agreements for the development of rapid diagnostic tests for Leishmaniasis and Leprosy, two 'neglected diseases' targeted by IDRI. The tests will be developed by Chembio using Chembio's patented Dual Path immunoassay test p...Gene Study Throws Up New Targets for Leishmaniasis
Gene sleuths believe they may have identified potential chinks in the parasite that causes leishmaniasis, a disfiguring and sometimes fatal disease that afflicts some 12 million people around the world . Their comparison of three species of protozoa that cause most cases of leishmaniasis could be a boon for drug engineers, whose budgets for tackling this neglected disease are already slen...